Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04928339 · ClinicalTrials.gov registry record · Phase 4
Pecto-Intercostal Fascial Plane Block Study
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT04928339 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 100 participants.
The verdict
NCT04928339, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study is being done to see if bilateral pecto-intercostal fascial plane blocks (PIFB) with a mixture of liposomal and standard bupivacaine decrease pain and opioid requirements in patients undergoing cardiac surgery via median sternotomy compared to controls (sham blocks with saline). 100 participants will be recruited and can expect to be on study for 100 days.
Interventions
- OTHER Saline
- DRUG Liposomal bupivacaine
- DRUG Bupivacaine Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04928339
The ClinicalTrials.gov registry entry for NCT04928339 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT04928339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04928339 about?
NCT04928339 is a clinical study titled "Pecto-Intercostal Fascial Plane Block Study". This study is being done to see if bilateral pecto-intercostal fascial plane blocks (PIFB) with a mixture of liposomal and standard bupivacaine decrease pain and opioid requirements in patients undergoing cardiac surgery via median sternotomy compared to controls (sham blocks with saline). 100 parti...
What is the current status of trial NCT04928339?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2022-03-28. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT04928339?
The interventions under investigation include: Saline (OTHER), Liposomal bupivacaine (DRUG), Bupivacaine Injection (DRUG).
Who is sponsoring clinical trial NCT04928339?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.